NCT00732108

Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness

Efficacy of Topiramate in Patients Wih Migraine-Associated Dizziness

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether topiramate effective in treating dizziness symptoms that are associated with migraine headaches.

Detailed description

Migraine is a common disorder, often associated with dizziness symptoms. In many cases, dizziness is one of the only manifestations of migraine headaches. Various classes of drugs have been advocated as treatment for migraine-associated dizziness, though none has been shown to be superior over the others. Topiramate is a drug approved for migraine prophylaxis. This study is designed to assess if there are significant changes in dizziness frequency and severity in patients diagnosed with migraine-associated dizziness treated with topiramate. Demonstrating benefit of topiramate with a placebo-controlled study to alleviate symptoms of dizziness would serve to clarify effective treatment options for patients with migraine-associated dizziness.

Conditions

• Migraine
• Headache
• Dizziness

Interventions

Type	Name	Description
DRUG	topiramate	50mg orally for 2 weeks, then 100mg orally for 6 weeks
DRUG	lactulose placebo pill	1 placebo pill orally for 2 weeks, then 2 placebo pills orally for 6 weeks

Timeline

• Start date: 2008-11-01
• Primary completion: 2011-08-01
• First posted: 2008-08-11
• Last updated: 2015-03-06

Locations

1 site across 1 country: United States